Department of Psychiatry and Psychology, School for Mental Health and Neuroscience, EURON, Maastricht University Medical Centre, Maastricht, the Netherlands.
Faculty of Psychology and Educational Sciences, Laboratory of Biological Psychology, University of Leuven, Leuven, Belgium.
Neuropsychopharmacology. 2020 Feb;45(3):534-541. doi: 10.1038/s41386-019-0467-8. Epub 2019 Jul 28.
Extinction learning is assumed to represent a core mechanism underlying exposure therapy. Empirical evaluations of this assumption, however, are largely lacking. The current study investigated whether neural activations and self-report outcomes during extinction learning and extinction recall could specifically predict exposure therapy response in specific phobia. In this double-blind randomized controlled trial, individuals with spider phobia (N = 45; female/male = 41/4) were on group basis randomly allocated to exposure therapy (n = 25; female/male = 24/1) or progressive muscle relaxation (PMR; n = 20; female/male = 17/3). Intervention effects were measured with the Fears of Spiders questionnaire. Participants also underwent a three-day fear conditioning, extinction learning, and extinction recall paradigm during functional magnetic resonance imaging at baseline. Extinction outcomes were self-reported fear and threat expectancy, and neural responses during conditioned stimulus processing and during extinction-related prediction errors (US omissions) in regions of interest (ventromedial prefrontal cortex (vmPFC) and nucleus accumbens). Results showed that exposure therapy resulted in stronger symptom reductions than PMR (Cohen's d = 0.90). Exposure therapy response was specifically predicted by prediction-error related vmPFC activation during early extinction. There were also indications vmPFC activations during conditioned safety stimulus processing at early extinction predicted therapy outcome. Neural activations during extinction recall and self-report data did however not predict therapy outcome. These findings indicate that exposure therapy may rely on neural extinction learning processes. Prediction errors are thought to drive the extinction learning process, and prediction error-related vmPFC activation specifically predicted therapy outcome. The extent to which vmPFC processes safety signals may additionally be predictive of exposure therapy response, but the specificity is less clear.
灭绝学习被认为是暴露疗法的核心机制。然而,对这一假设的实证评估在很大程度上是缺乏的。本研究调查了在特定恐惧症中,灭绝学习和灭绝回忆期间的神经激活和自我报告结果是否可以特异性地预测暴露疗法的反应。在这项双盲随机对照试验中,蜘蛛恐惧症患者(N=45;女性/男性=41/4)按组随机分配到暴露疗法组(n=25;女性/男性=24/1)或渐进性肌肉松弛组(PMR;n=20;女性/男性=17/3)。干预效果用蜘蛛恐惧问卷来衡量。参与者还在基线时接受了为期三天的恐惧条件反射、灭绝学习和灭绝回忆范式的功能性磁共振成像。灭绝结果是自我报告的恐惧和威胁预期,以及在条件刺激处理和与灭绝相关的预测误差(US 遗漏)期间的神经反应,在感兴趣的区域(腹内侧前额叶皮层(vmPFC)和伏隔核)。结果表明,暴露疗法比 PMR 产生更强的症状减轻(Cohen's d=0.90)。暴露疗法的反应与早期灭绝期间与预测误差相关的 vmPFC 激活特异性相关。也有迹象表明,早期灭绝期间条件性安全刺激处理期间的 vmPFC 激活预测了治疗结果。然而,灭绝回忆和自我报告数据的神经激活并不能预测治疗结果。这些发现表明,暴露疗法可能依赖于神经灭绝学习过程。预测误差被认为驱动灭绝学习过程,与预测误差相关的 vmPFC 激活特异性预测了治疗结果。vmPFC 过程安全信号的程度可能也可以预测暴露疗法的反应,但特异性不太清楚。